<scp>LC</scp> ‐ <scp>OCT</scp> for early diagnosis and characterization of dermatologic adverse events to oncologic drugs and correlation to histopathology
Pietro Sollena(Università Cattolica del Sacro Cuore), Ketty Peris(Università Cattolica del Sacro Cuore), Gerardo Palmisano(Università Cattolica del Sacro Cuore), Lucia Di Nardo(Università Cattolica del Sacro Cuore), Luca Pellegrino(Università Cattolica del Sacro Cuore), Maria Mannino(Università Cattolica del Sacro Cuore), Marisa Salvi(Università Cattolica del Sacro Cuore), Simone Cappilli(Università Cattolica del Sacro Cuore), Marica Marraffa(Università Cattolica del Sacro Cuore), Alessandro Di Stefani(University of Rome Tor Vergata)
Cited by 2
Related Papers
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment
|European Journal of Cancer|2020|324
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022
|European Journal of Cancer|2022|320
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022
|European Journal of Cancer|2022|287
Understanding the Molecular Genetics of Basal Cell Carcinoma
|International Journal of Molecular Sciences|2017|243